0.88
Precedente Chiudi:
$0.888
Aprire:
$0.91
Volume 24 ore:
24,617
Relative Volume:
0.27
Capitalizzazione di mercato:
$3.90M
Reddito:
-
Utile/perdita netta:
$-3.12M
Rapporto P/E:
-0.1828
EPS:
-4.8149
Flusso di cassa netto:
$-2.69M
1 W Prestazione:
-1.12%
1M Prestazione:
-22.12%
6M Prestazione:
-81.24%
1 anno Prestazione:
-51.11%
180 Life Sciences Corp Stock (ATNF) Company Profile
Nome
180 Life Sciences Corp
Settore
Industria
Telefono
650-507-0669
Indirizzo
3000 EL CAMINO REAL, PALO ALTO
Confronta ATNF con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ATNF
180 Life Sciences Corp
|
0.88 | 3.90M | 0 | -3.12M | -2.69M | -4.8149 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
490.47 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
585.49 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
599.87 | 36.96B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
236.75 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
252.77 | 25.74B | 3.81B | -644.79M | -669.77M | -6.24 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-09-15 | Iniziato | Maxim Group | Buy |
180 Life Sciences Corp Borsa (ATNF) Ultime notizie
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter
ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire
180 Life Sciences Corp. SEC 10-K Report - TradingView
ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com
180 Life Sciences Corp. (ATNF) reports earnings - qz.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 67.2% - Defense World
180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World
Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generation Therapies - openPR
180 Life Sciences (NASDAQ:ATNF) Given Sell (E+) Rating at Weiss Ratings - Defense World
180 Degree Capital (NASDAQ:TURN) Given Sell (D-) Rating at Weiss Ratings - Defense World
Synergy CHC (SNYR) Projected to Post Earnings on Monday - Defense World
Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drug - The Economic Times
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 29.3% in February - Defense World
Janone Inc. (NASDAQ:ALTS) Short Interest Up 40.9% in February - Defense World
180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Growth in Short Interest - Armenian Reporter
ATNF stock touches 52-week low at $1.1 amid market fluctuations - Investing.com
Contract wins and repeat business fuel progress at life sciences company - The Business Desk
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Down 50.4% in February - Defense World
Short Interest in ArrowMark Financial Corp. (NASDAQ:BANX) Expands By 62.6% - Defense World
American Rebel Holdings, Inc. (NASDAQ:AREB) Sees Large Growth in Short Interest - Defense World
ATNF stock touches 52-week low at $1.14 amid market shifts - Investing.com India
Global Dupuytrens Disease Market Deep Research 2025-2032 | Endo - openPR
180 Life Sciences Appoints New Chief Accounting Officer - TipRanks
180 Life Sciences (NASDAQ:ATNF) Receives Sell (E+) Rating from Weiss Ratings - Armenian Reporter
180 Life Sciences (NASDAQ:ATNF) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
TURN180 Degree Capital Corp Latest Stock News & Market Updates - StockTitan
180 Life Sciences Corp. modifies former CEO's exit terms - MSN
180 Life Sciences Corp. modifies former CEO’s exit terms By Investing.com - Investing.com India
180 Life Sciences Corp. modifies former CEO's exit terms By Investing.com - Investing.com Canada
180 Life Sciences Appoints New CEO Amid Leadership Changes - TipRanks
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
180 Life Sciences (NASDAQ:ATNF) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y - Yahoo Finance
Sai Life Sciences Shares Continue To Decline, Slumps Over 11% In A Week Despite Expansion Plans - Free Press Journal
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration - ACCESS Newswire
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules - ACCESS Newswire
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
180 Life Sciences Corp Azioni (ATNF) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):